Using sxRNA to Engineer Cellular Specificity in the CNS to Target Senescent Cells in Alzheimer’s Disease
- Achieving Cell-State Specificity by overcoming the limitations of conventional RNA delivery to target senescent cells in Alzheimer’s Disease
- Using sxRNA for conditional gene silencing through RNAi to activate only in target cells
- Designing a development path for preclinical validation of an sxRNA therapeutics targeting senescence